Home » Author Archive

Measured Wealth Private Client Group LLC Has $3.54 Million Stock Position in iShares S&P 100 ETF (NYSEARCA:OEF)

Measured Wealth Private Client Group LLC decreased its holdings in shares of iShares S&P 100 ETF (NYSEARCA:OEF) by 62.8% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 26,953 shares of the company’s stock after selling 45,413 shares during the period. iShares S&P 100 ETF makes up about 2.3% of Measured Wealth Private Client Group LLC’s holdings, making the stock its 8th largest holding. Measured Wealth Private Client Group LLC owned 0.07% of iShares S&P 100 ETF worth $3,544,000... 
 

Manning & Napier Group LLC Sells 45,195 Shares of Independence Realty Trust Inc (NYSE:IRT)

Manning & Napier Group LLC decreased its stake in shares of Independence Realty Trust Inc (NYSE:IRT) by 11.3% in the third quarter, Holdings Channel.com reports. The fund owned 355,040 shares of the real estate investment trust’s stock after selling 45,195 shares during the period. Manning & Napier Group LLC’s holdings in Independence Realty Trust were worth $5,080,000 at the end of the most recent reporting period. Several other large investors also recently modified their holdings of the stock. State of Alaska Department... 
 

Independent Bank Corp (NASDAQ:INDB) Shares Acquired by Rockland Trust Co.

Rockland Trust Co. increased its stake in shares of Independent Bank Corp (NASDAQ:INDB) by 20.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 698,441 shares of the bank’s stock after purchasing an additional 118,308 shares during the quarter. Independent Bank makes up approximately 4.5% of Rockland Trust Co.’s portfolio, making the stock its largest position. Rockland Trust Co.’s holdings in Independent Bank were worth $49,660,000 as of its most recent SEC filing.... 
 

Intellectus Partners LLC Lowers Stock Position in JPMorgan Chase & Co. (NYSE:JPM)

Intellectus Partners LLC reduced its stake in JPMorgan Chase & Co. (NYSE:JPM) by 0.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,603 shares of the financial services provider’s stock after selling 175 shares during the quarter. JPMorgan Chase & Co. comprises approximately 1.0% of Intellectus Partners LLC’s portfolio, making the stock its 22nd biggest holding. Intellectus Partners LLC’s holdings in JPMorgan... 
 

Hawkins (NASDAQ:HWKN) Lowered to “Hold” at BidaskClub

BidaskClub lowered shares of Hawkins (NASDAQ:HWKN) from a buy rating to a hold rating in a report published on Tuesday, BidAskClub reports. Other equities analysts have also issued research reports about the stock. TheStreet upgraded shares of Hawkins from a c+ rating to a b- rating in a report on Friday, July 5th. ValuEngine lowered shares of Hawkins from a hold rating to a sell rating in a report on Saturday, October 5th. Shares of HWKN opened at $39.61 on Tuesday. The firm has a market cap of $422.24 million, a PE ratio of 16.77 and a beta of... 
 

Cadogan Petroleum (LON:CAD) Stock Price Passes Below 50 Day Moving Average of $6.14

Cadogan Petroleum Plc (LON:CAD)’s share price crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $6.14 and traded as low as $5.00. Cadogan Petroleum shares last traded at $5.15, with a volume of 140,444 shares trading hands. The firm’s 50-day simple moving average is GBX 6.05 and its 200 day simple moving average is GBX 8.02. The company has a market cap of $12.08 million and a P/E ratio of 3.01. Cadogan Petroleum Company Profile (LON:CAD) Cadogan Petroleum plc, together with... 
 

TOR Minerals International (OTCMKTS:TORM) Stock Price Passes Above 50 Day Moving Average of $2.07

Shares of TOR Minerals International Inc (OTCMKTS:TORM) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $2.07 and traded as high as $1.71. TOR Minerals International shares last traded at $1.71, with a volume of 700 shares traded. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.32 and a current ratio of 3.12. The firm’s 50-day moving average price is $2.05 and its 200 day moving average price is $2.58. TOR Minerals International Company Profile (OTCMKTS:TORM) TOR... 
 

Crocs (NASDAQ:CROX) Price Target Increased to $34.00 by Analysts at Piper Jaffray Companies

Crocs (NASDAQ:CROX) had its price target boosted by Piper Jaffray Companies from $32.00 to $34.00 in a report released on Tuesday, BenzingaRatingsTable reports. Piper Jaffray Companies currently has an overweight rating on the textile maker’s stock. Piper Jaffray Companies also issued estimates for Crocs’ Q3 2019 earnings at $0.40 EPS, Q4 2019 earnings at $0.07 EPS, FY2019 earnings at $1.42 EPS, Q1 2020 earnings at $0.44 EPS, Q2 2020 earnings at $0.67 EPS, Q4 2020 earnings at $0.13 EPS and FY2020 earnings at $1.72 EPS. Several other... 
 

Morgan Stanley Trims Virtus Investment Partners (NASDAQ:VRTS) Target Price to $106.00

Virtus Investment Partners (NASDAQ:VRTS) had its price objective cut by Morgan Stanley from $108.00 to $106.00 in a report released on Tuesday morning, BenzingaRatingsTable reports. They currently have an equal weight rating on the closed-end fund’s stock. A number of other equities research analysts also recently commented on the company. BidaskClub downgraded Virtus Investment Partners from a hold rating to a sell rating in a research report on Friday, October 4th. ValuEngine upgraded Virtus Investment Partners from a strong sell rating... 
 

Trinity Biotech (NASDAQ:TRIB) Downgraded to “Sell” at ValuEngine

Trinity Biotech (NASDAQ:TRIB) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a report released on Thursday, ValuEngine reports. Shares of NASDAQ:TRIB opened at $0.95 on Thursday. The company has a debt-to-equity ratio of 2.09, a current ratio of 3.36 and a quick ratio of 2.07. Trinity Biotech has a 12 month low of $0.93 and a 12 month high of $4.01. The stock’s 50 day moving average price is $1.28 and its 200 day moving average price is $2.03. Trinity Biotech (NASDAQ:TRIB)... 
 

Macy’s Inc (NYSE:M) Shares Bought by Rockland Trust Co.

Rockland Trust Co. boosted its stake in shares of Macy’s Inc (NYSE:M) by 37.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 80,566 shares of the company’s stock after buying an additional 21,839 shares during the quarter. Rockland Trust Co.’s holdings in Macy’s were worth $1,192,000 as of its most recent filing with the Securities and Exchange Commission. A number of other institutional investors and hedge funds also recently modified their... 
 

Teladoc Health (NYSE:TDOC) Stock Rating Lowered by ValuEngine

Teladoc Health (NYSE:TDOC) was downgraded by analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research report issued on Thursday, ValuEngine reports. A number of other research firms also recently weighed in on TDOC. Bank of America started coverage on Teladoc Health in a report on Thursday, June 13th. They set a “buy” rating and a $65.00 target price for the company. Deutsche Bank assumed coverage on Teladoc Health in a research note on Thursday, September 12th. They issued a “buy”... 
 

QAD (NASDAQ:QADA) Cut to “Buy” at ValuEngine

QAD (NASDAQ:QADA) was downgraded by research analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research note issued on Thursday, ValuEngine reports. A number of other equities analysts have also issued reports on the company. Zacks Investment Research upgraded QAD from a “hold” rating to a “buy” rating and set a $44.00 target price for the company in a research note on Tuesday, August 13th. BidaskClub upgraded QAD from a “buy” rating to a “strong-buy”... 
 

RMR Group Inc (NASDAQ:RMR) Receives $54.67 Average Price Target from Analysts

Shares of RMR Group Inc (NASDAQ:RMR) have received an average recommendation of “Hold” from the eleven analysts that are covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $54.00. Several analysts have issued reports on the company. Oppenheimer raised RMR Group from a... 
 

Ferroglobe PLC (NASDAQ:GSM) Receives Average Rating of “Hold” from Analysts

Ferroglobe PLC (NASDAQ:GSM) has earned a consensus rating of “Hold” from the nine research firms that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, six have given a hold rating and one has given a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $5.57. Several equities research analysts recently issued reports on GSM shares. Stifel Nicolaus lowered shares of Ferroglobe from... 
 

Target Capital (CVE:TCI) Shares Down 33.3%

Target Capital Inc (CVE:TCI)’s stock price was down 33.3% on Thursday . The stock traded as low as C$0.01 and last traded at C$0.01, approximately 514,500 shares traded hands during trading. An increase of 136% from the average daily volume of 217,590 shares. The stock had previously closed at C$0.02. The firm has a market capitalization of $2.13 million and a P/E ratio of -2.14. The firm has a 50-day moving average price of C$0.02 and a two-hundred day moving average price of C$0.03. The company has a debt-to-equity ratio of 0.00, a current... 
 

Azarga Metals (CVE:AZR) Sets New 52-Week Low at $0.06

Azarga Metals Corp (CVE:AZR) shares reached a new 52-week low during trading on Thursday . The company traded as low as C$0.06 and last traded at C$0.07, with a volume of 9000 shares traded. The stock had previously closed at C$0.10. The company has a debt-to-equity ratio of 28.15, a quick ratio of 2.00 and a current ratio of 2.18. The stock has a 50 day moving average price of C$0.08 and a 200 day moving average price of C$0.10. The company has a market cap of $7.28 million and a P/E ratio of -5.00. About Azarga Metals (CVE:AZR) Azarga Metals... 
 

Trigon Metals (CVE:TM) Sets New 52-Week High at $0.19

Trigon Metals Inc (CVE:TM) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as C$0.19 and last traded at C$0.18, with a volume of 66500 shares. The stock had previously closed at C$0.17. The firm has a market capitalization of $9.37 million and a P/E ratio of -2.40. The company’s 50 day moving average is C$0.15 and its 200-day moving average is C$0.11. Trigon Metals Company Profile (CVE:TM) Trigon Metals Inc, together with its subsidiaries, engages in the acquisition, exploration, development, and maintenance... 
 

International Frontier Resources (CVE:IFR) Sets New 1-Year Low at $0.02

International Frontier Resources Corp. (CVE:IFR)’s share price hit a new 52-week low on Thursday . The stock traded as low as C$0.02 and last traded at C$0.02, with a volume of 7000 shares trading hands. The stock had previously closed at C$0.02. The stock has a market capitalization of $2.61 million and a P/E ratio of -0.29. The company has a fifty day moving average of C$0.02 and a two-hundred day moving average of C$0.06. About International Frontier Resources (CVE:IFR) International Frontier Resources Corporation acquires, develops, exploits,... 
 

Svb Leerink Initiates Coverage on Satsuma Pharmaceuticals (NASDAQ:STSA)

Svb Leerink initiated coverage on shares of Satsuma Pharmaceuticals (NASDAQ:STSA) in a report issued on Tuesday, Briefing.com Automated Import reports. The firm issued an outperform rating on the financial services provider’s stock. Svb Leerink also issued estimates for Satsuma Pharmaceuticals’ Q3 2019 earnings at ($1.01) EPS, Q4 2019 earnings at ($0.81) EPS, FY2019 earnings at ($3.15) EPS, FY2020 earnings at ($2.55) EPS, FY2021 earnings at ($2.05) EPS, FY2022 earnings at ($2.95) EPS and FY2023 earnings at ($2.70) EPS. Shares of STSA... 
 

Harvest One Cannabis (CVE:HVT) Hits New 1-Year Low at $0.33

Shares of Harvest One Cannabis Inc (CVE:HVT) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as C$0.33 and last traded at C$0.34, with a volume of 162992 shares trading hands. The stock had previously closed at C$0.36. The company has a market cap of $72.99 million and a price-to-earnings ratio of -3.00. The company has a current ratio of 7.74, a quick ratio of 6.16 and a debt-to-equity ratio of 0.27. The firm’s fifty day moving average price is C$0.47 and its 200-day moving average price is C$0.67. About... 
 

Rockland Trust Co. Has $604,000 Stock Holdings in SPDR S&P Bank ETF (NYSEARCA:KBE)

Rockland Trust Co. lifted its holdings in shares of SPDR S&P Bank ETF (NYSEARCA:KBE) by 20.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,510 shares of the exchange traded fund’s stock after buying an additional 2,445 shares during the period. Rockland Trust Co.’s holdings in SPDR S&P Bank ETF were worth $604,000 at the end of the most recent quarter. Several other institutional investors have also bought and sold shares of KBE.... 
 

Zacks: Brokerages Anticipate Imv Inc (NYSE:IMV) to Post -$0.09 Earnings Per Share

Wall Street analysts forecast that Imv Inc (NYSE:IMV) will report earnings per share of ($0.09) for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for IMV’s earnings, with the highest EPS estimate coming in at ($0.08) and the lowest estimate coming in at ($0.11). IMV posted earnings per share of ($0.11) in the same quarter last year, which would indicate a positive year over year growth rate of 18.2%. The firm is expected to report its next earnings results on Friday, November 1st. On average, analysts... 
 

Verona Pharma (LON:VRP) Share Price Crosses Below Two Hundred Day Moving Average of $54.07

Verona Pharma Plc (LON:VRP)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $54.07 and traded as low as $48.00. Verona Pharma shares last traded at $48.70, with a volume of 1,856 shares traded. Separately, Shore Capital reissued a “buy” rating on shares of Verona Pharma in a report on Monday, August 5th. The business has a fifty day moving average price of GBX 47.26 and a 200 day moving average price of GBX 53.99. The company has a debt-to-equity ratio... 
 

IQE (LON:IQE) Rating Reiterated by Peel Hunt

IQE (LON:IQE)‘s stock had its “buy” rating restated by investment analysts at Peel Hunt in a research note issued to investors on Thursday, LSE.Co.UK reports. They presently have a GBX 108 ($1.41) target price on the stock. Peel Hunt’s price objective indicates a potential upside of 70.08% from the company’s current price. Several other research analysts have also issued reports on IQE. Canaccord Genuity lowered IQE to a “speculative buy” rating and decreased their target price for the stock from GBX 85... 
 

Cohort (LON:CHRT) Stock Crosses Below Two Hundred Day Moving Average of $428.41

Cohort PLC (LON:CHRT)’s stock price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $428.41 and traded as low as $510.00. Cohort shares last traded at $510.00, with a volume of 6,447 shares. The company has a debt-to-equity ratio of 32.72, a quick ratio of 1.44 and a current ratio of 2.08. The firm has a market capitalization of $210.94 million and a price-to-earnings ratio of 38.72. The business has a fifty day moving average of GBX 484.68 and a two-hundred day... 
 

Phibro Animal Health Corp (NASDAQ:PAHC) Expected to Announce Earnings of $0.22 Per Share

Brokerages predict that Phibro Animal Health Corp (NASDAQ:PAHC) will report $0.22 earnings per share for the current fiscal quarter, according to Zacks. Zero analysts have made estimates for Phibro Animal Health’s earnings. The highest EPS estimate is $0.25 and the lowest is $0.19. Phibro Animal Health reported earnings per share of $0.39 during the same quarter last year, which would indicate a negative year over year growth rate of 43.6%. The firm is scheduled to issue its next quarterly earnings report on Tuesday, November 5th. On average,... 
 

Ocugen (NASDAQ:OCGN) Director Purchases $96,031.02 in Stock

Ocugen (NASDAQ:OCGN) Director Junge Zhang bought 31,078 shares of the firm’s stock in a transaction on Monday, September 30th. The stock was acquired at an average cost of $3.09 per share, for a total transaction of $96,031.02. OCGN opened at $1.53 on Friday. Ocugen has a 1-year low of $1.22 and a 1-year high of $57.00. The company has a market capitalization of $2.42 million, a price-to-earnings ratio of -0.03 and a beta of 3.00. Ocugen (NASDAQ:OCGN) last released its earnings results on Friday, August 9th. The company reported ($1.80)... 
 

Staffline Group (LON:STAF) Share Price Passes Below Two Hundred Day Moving Average of $419.36

Shares of Staffline Group Plc (LON:STAF) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $419.36 and traded as low as $95.48. Staffline Group shares last traded at $102.00, with a volume of 114,544 shares changing hands. STAF has been the topic of a number of recent research reports. Liberum Capital reaffirmed an “under review” rating on shares of Staffline Group in a research report on Tuesday, September 17th. Berenberg Bank cut shares of Staffline Group... 
 

Insider Selling: Horace Mann Educators Co. (NYSE:HMN) EVP Sells $158,550.00 in Stock

Horace Mann Educators Co. (NYSE:HMN) EVP Matthew P. Sharpe sold 3,500 shares of the stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $45.30, for a total value of $158,550.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Matthew P. Sharpe also recently made the following trade(s): On Friday, September 6th, Matthew P. Sharpe sold 3,500 shares of Horace Mann Educators stock. The shares were sold at an average price... 
 

American Campus Communities (NYSE:ACC) Lowered to Hold at Zacks Investment Research

Zacks Investment Research downgraded shares of American Campus Communities (NYSE:ACC) from a buy rating to a hold rating in a research note released on Tuesday morning, Zacks.com reports. According to Zacks, “American Campus Communities, Inc. is a real estate investment trust (REIT). Through ACC’s controlling interest in American Campus Communities Operating Partnership L.P. (ACCOP), ACC is one of the largest owners, managers and developers of high quality student housing properties in the United States in terms of beds owned and under... 
 

Affiliated Managers Group (NYSE:AMG) Given New $85.00 Price Target at Bank of America

Affiliated Managers Group (NYSE:AMG) had its price objective raised by Bank of America from $75.00 to $85.00 in a research note issued to investors on Tuesday, Briefing.com Automated Import reports. They currently have an underperform rating on the asset manager’s stock. Several other equities analysts also recently issued reports on the stock. Barrington Research cut their price objective on shares of Affiliated Managers Group from $135.00 to $125.00 and set an outperform rating on the stock in a report on Monday, July 29th. Citigroup cut... 
 

GlaxoSmithKline’s (GSK) “Equal Weight” Rating Reiterated at Barclays

Barclays reaffirmed their equal weight rating on shares of GlaxoSmithKline (LON:GSK) in a research note released on Wednesday morning, Digital Look reports. They currently have a GBX 1,600 ($20.91) price objective on the stock. GSK has been the topic of several other research reports. Citigroup reissued a neutral rating on shares of GlaxoSmithKline in a research note on Tuesday, September 3rd. UBS Group reissued a neutral rating and set a GBX 1,610 ($21.04) price target (up previously from GBX 1,610 ($21.04)) on shares of GlaxoSmithKline in a... 
 

M. Kraus & Co Boosts Stock Position in Johnson & Johnson (NYSE:JNJ)

M. Kraus & Co lifted its position in Johnson & Johnson (NYSE:JNJ) by 4.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 47,181 shares of the company’s stock after buying an additional 1,986 shares during the quarter. Johnson & Johnson makes up 3.3% of M. Kraus & Co’s investment portfolio, making the stock its 16th largest holding. M. Kraus & Co’s holdings in Johnson & Johnson were worth $6,104,000 at the end of the most recent quarter.... 
 

Viavi Solutions Inc (NASDAQ:VIAV) Receives $15.25 Consensus PT from Brokerages

Viavi Solutions Inc (NASDAQ:VIAV) has received an average recommendation of “Buy” from the eleven analysts that are currently covering the firm, Marketbeat reports. Four analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $15.25. VIAV has been the subject of a number of recent analyst reports. TheStreet raised shares of Viavi Solutions from a “c+” rating to a “b”... 
 

Welch & Forbes LLC Acquires 4,711 Shares of Vanguard FTSE All-World ex-US ETF (NYSEARCA:VEU)

Welch & Forbes LLC lifted its holdings in Vanguard FTSE All-World ex-US ETF (NYSEARCA:VEU) by 4.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 116,829 shares of the company’s stock after purchasing an additional 4,711 shares during the quarter. Welch & Forbes LLC’s holdings in Vanguard FTSE All-World ex-US ETF were worth $5,830,000 as of its most recent SEC filing. A number of other institutional investors... 
 

Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO) Shares Sold by Welch & Forbes LLC

Welch & Forbes LLC trimmed its stake in shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO) by 1.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 81,984 shares of the exchange traded fund’s stock after selling 877 shares during the quarter. Welch & Forbes LLC’s holdings in Vanguard FTSE Emerging Markets ETF were worth $3,301,000 as of its most recent filing with the Securities and Exchange Commission. A number of other institutional investors... 
 

Welch & Forbes LLC Has $8.10 Million Stock Position in Arthur J Gallagher & Co (NYSE:AJG)

Welch & Forbes LLC grew its holdings in Arthur J Gallagher & Co (NYSE:AJG) by 17.6% during the third quarter, Holdings Channel.com reports. The firm owned 90,474 shares of the financial services provider’s stock after acquiring an additional 13,565 shares during the quarter. Welch & Forbes LLC’s holdings in Arthur J Gallagher & Co were worth $8,104,000 as of its most recent SEC filing. Several other hedge funds and other institutional investors have also bought and sold shares of the company. HM Payson & Co. bought... 
 

Welch & Forbes LLC Raises Holdings in SPDR S&P Dividend ETF (NYSEARCA:SDY)

Welch & Forbes LLC boosted its stake in shares of SPDR S&P Dividend ETF (NYSEARCA:SDY) by 10.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,794 shares of the company’s stock after purchasing an additional 2,246 shares during the quarter. Welch & Forbes LLC’s holdings in SPDR S&P Dividend ETF were worth $2,544,000 as of its most recent SEC filing. A number of other hedge funds and other institutional investors also recently... 
 

Caterpillar Inc. (NYSE:CAT) Shares Sold by Welch & Forbes LLC

Welch & Forbes LLC decreased its holdings in Caterpillar Inc. (NYSE:CAT) by 13.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 32,907 shares of the industrial products company’s stock after selling 5,050 shares during the quarter. Welch & Forbes LLC’s holdings in Caterpillar were worth $4,157,000 at the end of the most recent reporting period. A number of other hedge funds and other institutional investors have also added to or reduced their stakes in... 
 

Employers Holdings, Inc. (NYSE:EIG) Shares Acquired by Dalton Greiner Hartman Maher & Co.

Dalton Greiner Hartman Maher & Co. boosted its stake in shares of Employers Holdings, Inc. (NYSE:EIG) by 9.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 132,973 shares of the financial services provider’s stock after purchasing an additional 11,085 shares during the quarter. Dalton Greiner Hartman Maher & Co. owned approximately 0.42% of Employers worth $5,795,000 at the end of the most recent reporting period. Other large investors also recently added... 
 

Carroll Financial Associates Inc. Has $117,000 Position in Global X Robotics & Artificial Intelligence Thematic ETF (NASDAQ:BOTZ)

Carroll Financial Associates Inc. lifted its stake in Global X Robotics & Artificial Intelligence Thematic ETF (NASDAQ:BOTZ) by 47.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,862 shares of the company’s stock after purchasing an additional 1,887 shares during the period. Carroll Financial Associates Inc.’s holdings in Global X Robotics & Artificial Intelligence Thematic ETF were worth $117,000 at the end... 
 

Canton Hathaway LLC Has $491,000 Position in SPDR S&P 500 ETF Trust (NYSEARCA:SPY)

Canton Hathaway LLC lowered its holdings in SPDR S&P 500 ETF Trust (NYSEARCA:SPY) by 17.8% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,656 shares of the company’s stock after selling 359 shares during the quarter. Canton Hathaway LLC’s holdings in SPDR S&P 500 ETF Trust were worth $491,000 as of its most recent SEC filing. A number of other hedge funds and other institutional investors have also bought and sold shares of SPY. Morgan Stanley boosted its holdings in SPDR S&P 500 ETF Trust by 29.6% during... 
 

LCNB (NASDAQ:LCNB) Upgraded to Hold by Zacks Investment Research

Zacks Investment Research upgraded shares of LCNB (NASDAQ:LCNB) from a sell rating to a hold rating in a research report sent to investors on Tuesday morning, Zacks.com reports. According to Zacks, “LCNB Corp. is a financial holding company. The Company, through its subsidiaries, LCNB National Bank and Dakin Insurance Agency, Inc., is engaged in the commercial banking and insurance agency businesses. Headquartered in Lebanon, Ohio, the Bank is a full service community bank offering a range of commercial and personal banking services. In addition,... 
 

Capital Investment Services of America Inc. Acquires 676 Shares of Amazon.com, Inc. (NASDAQ:AMZN)

Capital Investment Services of America Inc. boosted its holdings in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 14.1% during the 3rd quarter, Holdings Channel reports. The firm owned 5,455 shares of the e-commerce giant’s stock after buying an additional 676 shares during the period. Capital Investment Services of America Inc.’s holdings in Amazon.com were worth $9,469,000 at the end of the most recent reporting period. A number of other institutional investors and hedge funds have also modified their holdings of the stock. Gulf International... 
 

Carroll Financial Associates Inc. Has $188,000 Stock Holdings in FleetCor Technologies, Inc. (NYSE:FLT)

Carroll Financial Associates Inc. increased its holdings in FleetCor Technologies, Inc. (NYSE:FLT) by 3,758.8% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 656 shares of the business services provider’s stock after buying an additional 639 shares during the quarter. Carroll Financial Associates Inc.’s holdings in FleetCor Technologies were worth $188,000 at the end of the most recent reporting period. A number of other large investors have also bought and sold shares of FLT. Lazard Asset Management LLC acquired a... 
 

Acasti Pharma (NASDAQ:ACST) Stock Rating Lowered by ValuEngine

ValuEngine lowered shares of Acasti Pharma (NASDAQ:ACST) from a sell rating to a strong sell rating in a report issued on Tuesday morning, ValuEngine reports. A number of other analysts also recently issued reports on the stock. Aegis initiated coverage on shares of Acasti Pharma in a report on Tuesday, July 9th. They set a buy rating for the company. Oppenheimer initiated coverage on shares of Acasti Pharma in a report on Thursday, July 18th. They set an outperform rating and a $7.00 price objective for the company. Zacks Investment Research downgraded... 
 

Molina Healthcare, Inc. (NYSE:MOH) Shares Sold by Cambridge Investment Research Advisors Inc.

Cambridge Investment Research Advisors Inc. lowered its position in Molina Healthcare, Inc. (NYSE:MOH) by 45.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,474 shares of the company’s stock after selling 2,097 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Molina Healthcare were worth $354,000 at the end of the most recent quarter. A number of other hedge funds have also recently modified... 
 

Cambridge Investment Research Advisors Inc. Grows Stock Holdings in Arch Capital Group Ltd. (NASDAQ:ACGL)

Cambridge Investment Research Advisors Inc. boosted its position in Arch Capital Group Ltd. (NASDAQ:ACGL) by 7.6% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 9,908 shares of the insurance provider’s stock after acquiring an additional 700 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Arch Capital Group were worth $367,000 at the end of the most recent reporting period. A number of other hedge funds have also recently added to or reduced their stakes in the... 
 

Cambridge Investment Research Advisors Inc. Makes New $414,000 Investment in Banner Co. (NASDAQ:BANR)

Cambridge Investment Research Advisors Inc. bought a new position in Banner Co. (NASDAQ:BANR) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 7,648 shares of the financial services provider’s stock, valued at approximately $414,000. Other hedge funds and other institutional investors also recently bought and sold shares of the company. US Bancorp DE lifted its position in shares of Banner by 6.4% in the second quarter. US Bancorp DE now owns 3,642 shares of the financial... 
 
© 2006-2019 Zolmax.